Cleveland Clinic Abu Dhabi (CCAD)

Cleveland Clinic Abu Dhabi (CCAD) is a unique and unparalleled extension of US-based Cleveland Clinic's model of care, specifically designed to address a range of complex and critical care requirements unique to the residents and communities of the United Arab Emirates. Cleveland Clinic Abu Dhabi (CCAD) is composed of 15 institutes designed to put Patients First and align with the region's specific healthcare needs. In all, more than 50 medical and surgical specialties are represented at Cleveland Clinic Abu Dhabi (CCAD) and are integrated to offer coordinated, multidisciplinary care for adult patients.

The facilities at Cleveland Clinic Abu Dhabi (CCAD) combine state-of-the-art amenities and world-class service standards. The hospital is a 364 (expandable to 490) bed facility, with five clinical floors, three diagnostic and treatment levels, and 13 floors of critical and acute inpatient units. It is a physician-led medical facility served by Western-trained, North American/European board certified (or equivalent) physicians, licensed by the Department of Health - Abu Dhabi. Cleveland Clinic Abu Dhabi (CCAD) provides patients in the region direct access to the world's best healthcare providers and Cleveland Clinic's unique model of care, reducing their need to travel abroad for treatment

Visit Site

International Lymphoma Radiation Oncology Group (ILROG)

The International Lymphoma Radiation Oncology Group (ILROG) was established in 2010 by leading radiation oncology experts from across the globe, recognized as academic authorities in the treatment of lymphoma. The initiative was met with strong support from more than 750 radiation oncologists in over 40 countries, leading to the formation of a Steering Committee of 24 specialists representing 14 nations, spanning from Asia to North America.The Steering Committee prioritized the development, harmonization, and dissemination of updated guidelines to reflect rapid advances in principles, dose concepts, and technology in lymphoma radiotherapy. Today, ILROG continues to expand its membership and welcomes radiation oncologists with an interest in lymphoma to participate actively in committees, research collaborations, and special mission teams dedicated to advancing the field.

Visit Site